1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol has been researched along with lomustine in 3 studies
Studies (1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol) | Trials (1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol) | Recent Studies (post-2010) (1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol) | Studies (lomustine) | Trials (lomustine) | Recent Studies (post-2010) (lomustine) |
---|---|---|---|---|---|
19 | 0 | 0 | 1,975 | 492 | 274 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Siemann, DW; Sutherland, RM | 1 |
Siemann, DW | 2 |
3 other study(ies) available for 1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol and lomustine
Article | Year |
---|---|
Potentiation of alkylating chemotherapy by dual function nitrofurans in multi-cell spheroids and solid tumors.
Topics: Animals; Antineoplastic Agents; Aziridines; Bone Marrow; Carcinoma; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Lomustine; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Misonidazole; Nitrofurans; Radiation-Sensitizing Agents; Sarcoma, Experimental; Stem Cells; Tumor Cells, Cultured | 1992 |
Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Hypoxia; Cyclophosphamide; Drug Synergism; Female; Hydralazine; Lomustine; Melphalan; Mice; Mice, Inbred C3H; Misonidazole; Sarcoma, Experimental; Stem Cells | 1990 |
The chemosensitizing and cytotoxic effects of RSU 1164 and RSU 1165 in a murine tumor model.
Topics: Animals; Antineoplastic Agents; Cell Survival; Drug Synergism; Lomustine; Mice; Misonidazole; Oxygen; Radiation-Sensitizing Agents; Sarcoma, Experimental; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1989 |